FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters
Quick Insights
The Bottom Line
The FDA will consider easing restrictions on unproven peptide injections favored by RFK Jr. and MAHA supporters.
How This Affects You
If restrictions are eased, you might have broader access to unproven peptide therapies, but their safety and effectiveness are not fully regulated.
AI Summary
The Food and Drug Administration (FDA) will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections. These peptides are a group of unapproved therapies that have gained popularity among wellness influencers, fitness gurus, and celebrities. The move is significant as these unproven treatments are notably favored by figures like RFK Jr. and MAHA supporters. This FDA consideration could potentially broaden access to therapies currently without full regulatory approval.
What's Being Done
The FDA will hold a meeting this summer to consider easing restrictions on peptide injections.
Source Coverage Map
2 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
1 sourceMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Trump Administration Actions and Policies
The Trump administration is taking various actions, including restarting the Global Entry program, pushing for college sports legislation, and facing scrutiny over its handling of the Iran conflict and its impact on the State Department.
Government Spending & Oversight
Tracking how taxpayer dollars are spent, where oversight gaps exist, and what watchdogs are uncovering. From federal budget battles and earmark controversies to inspector general reports and GAO audits, this deep dive follows the money trail through every level of government. We examine defense spending, entitlement programs, infrastructure investments, and the growing national debt — focusing on accountability, waste, and the policies that shape how America allocates its resources.
Robert F. Kennedy Jr. and Health Policy
Health and Human Services Secretary Robert F. Kennedy Jr. is actively engaged in policy discussions, testifying before Congress and advocating for changes in FDA regulations. His focus includes easing limits on unproven peptides, a stance that aligns with his 'Make America Healthy Again' initiative.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures - AP News
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPS1dwQkFyRkUtSGppUmY5MzdRSWdtbnZNQlNCUDlKOTlocDlqWlZEMlBOcUFvdFVzdFNJeDNJVFE1blRScm92S0hPQU4yUzMtdkprWGZvcVQwZkZaMGhkQWZVdkVxUVRmRFRHMkZaMnRTOUdYNThOUG8xQlhWSDVQemZKc0ZlVkZvcnNRRnQzazNxU0R0SnY3eF9QeGlDZw?oc=5" target="_blank">FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures</a> <font color="#6f6f6f">AP News</font>
HealthRFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban
HealthUS states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
<p>Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity</p><p>Faced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.</p><p>The pullback stems from the dramatic increase in public spending on drugs such as Ozempic and Wegovy in recent years.</p> <a href="https://www.theguardian.com/us-news/2026/apr/14/states-medicaid-coverage-glp-1">Continue reading...</a>
PoliticsBenin holds presidential election with finance minister favored to succeed Talon - AP News
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPNGZsTTQ5Z0ctbDc3S1hrNjd0akwwRC1ESlFiZzBZaWM2dGNhdjlVcHZsSFZNcHo1by1hN1JFR1B5YXk4VWtkbmhPeTlFbDFHejZ4bm81TXZ4YVhzbkVPT01OZ3ZrYjQ4UWJCdDdMNGxwUk9ETWdyS3g2b2NDdl84MFJVc1k3NklmQm5lcU1QdTBGR283WTNkNGRkd183cEc5VUE?oc=5" target="_blank">Benin holds presidential election with finance minister favored to succeed Talon</a> <font color="#6f6f6f">AP News</font>
HealthCough drops sold nationwide recalled: FDA
A China-based company is voluntarily recalling numerous cough drop products sold across the U.S., according to the Food and Drug Administration.
HealthFACT FOCUS: RFK Jr. says the US is limiting measles outbreaks better than the rest of the world - AP News
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQjd0LTJtWDBxak1jZEQ0cnVIRGNvR1R3djROM0daOVNTVkpfVXhuNm1xdkFxMGZsZHZDVWhvOURjYl94cmVPeXF0aHg0dmdGbm1HeXJzd1R2MDJpRlRCV0dHRkViaW14ZEEydkVMM000ZTlselYzVzJEci1FTHRzVTl1Q28yM2NoUk9ZNnJhd3FhSXIwa1Z2cFhwQ19UWmNRNEY1UUtQOW1fUQ?oc=5" target="_blank">FACT FOCUS: RFK Jr. says the US is limiting measles outbreaks better than the rest of the world</a> <font color="#6f6f6f">AP News</font>
Texas Medical Board Sanctions Three Doctors for Delayed Care That Led to the Deaths of Two Pregnant Women
The post Texas Medical Board Sanctions Three Doctors for Delayed Care That Led to the Deaths of Two Pregnant Women appeared first on ProPublica .
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
What to know about Eric Swalwell’s exit from Congress and the California governor’s race - AP News
Anthony Albanese urges Israel to stop Lebanon attacks that intensified during Middle East ceasefire
Bipartisan duo that pushed Swalwell, Gonzales to resign says other lawmakers may be next
Blanche: Americans should be ‘happy’ about Trump directives to DOJ
California woman says she was raped by Rep. Eric Swalwell in 2018 - AP News
